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The Pro162 Variant is a Loss-of-Function Mutation of the
Human Melanocortin 1 Receptor Gene
To the Editor:
a melanocyte-stimulating hormone (aMSH) stimulates mamma-
lian melanocytes differentiation and/or proliferation (Abdel-Malek
et al, 1995), by binding to the G protein-coupled melanocortin 1
receptor (MC1R) and triggering the cAMP cascade. The gene
encoding for human MC1R was simultaneously cloned by
Mountjoy et al (1992) and Chhajlani and Wikberg (1992), who
reported slightly different sequences. Mammalian pigmentation
depends, among other factors, on the relative amounts of skin
eumelanin and pheomelanin (Thody and Graham, 1998). In man,
MC1R loss-of-function mutations, such as Arg151Cys, are causally
associated with predominantly pheomelanic red hair (reviewed by
Rees, 2000). Because red hair is a risk factor for increased UV
radiation skin sensitivity, a relationship of MC1R allelic variants and
skin cancer susceptibility has been investigated. Evidence has been
presented for an association between the Arg151Cys, Arg160Trp,
and Asp294His variants, red hair, and melanoma (Palmer et al,
2000).
The study of MC1R structure±function relationships and its
association with complex traits is complicated by the high
polymorphism of the gene (Rees, 2000). The functional effects
of many amino acid substitutions are debated or unknown.
Moreover, the reported wild-type sequences differ in potentially
relevant residues. An intriguing variant, originally reported as a
wild-type allele, displays a proline at position 162 (Mountjoy et al,
1992), in the interface between the second cytosolic loop and the
fourth transmembrane fragment, instead of an arginine residue
reported by others (Chhajlani and Wikberg, 1992; Tan et al, 1999).
Because Pro residues distort helical structures, an Arg/Pro substi-
tution at the beginning of a transmembrane fragment could be
functionally important.
In a survey of MC1R variants in cultured human melanoma and
giant congenital nevus cells, performed by sequencing the entire
coding sequence, we failed to ®nd the Pro162 allele in 10 samples
(Fig 1A, consensus sequence deposited in GenBank, number
AF326275). Unfortunately, no data are available as to the
pigmentation phenotypes of the patients/donors. This prompted
us to screen a larger number of samples by allele-speci®c PCR (AS-
PCR). Thirty healthy individuals were selected, of which 13 had
fair skin and poor tanning ability, whereas 17 had black hair and a
high basal pigmentation and tanning response. We used an arti®cial
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Figure 1. Identi®cation of the Arg162 allele as the wild-type form
of MC1R. The MC1R coding sequence was ampli®ed from genomic
DNA using Pfu polymerase and primers CCTAAGCTTACTCC-
TTCCTGCTTCCTGGACA (forward, nt 435±456) and CTG-
GAATTCACACTTAAAGCGCGTGCACCGC (reverse, nt 1418±
1439), designed from the sequence reported by Mountjoy et al (1992),
GenBank entry X65634, and containing added Hind III and EcoR I sites
(underlined) for cloning in pcDNA3 (Invitrogen, Carlsbad, CA). (A)
Sequence of amplicons from a human melanoma cell line (left), and a
Pro162 construct (right), used as sequencing quality control. The
relevant codon is highlighted, and the mutated base shown by an arrow.
(B) Inability to detect the Pro162 variant by AS-PCR of genomic DNA.
Forward primers TGACCCTGCCGCGGGCGCG (R, speci®c for the
Arg162 form) and TGACCCTGCCGCGGGCGCC (P, for the Pro162
variant), where the nucleotide responsible for speci®city is shown in
bold, were used with the reverse primer described above, and 1 mg of
genomic DNA or 12 pg of the Pro162 pcDNA3 construct as target.
PCR reactions with the speci®c primer sets for Pro (P) and Arg (R)
alleles, as indicated over each lane, were analyzed by agarose gel
electrophoresis. A blank reaction, without added target (labeled B), and a
100 bp ladder (®rst lane, left) are shown.
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Pro162 construct, generated by site-directed mutagenesis and
cloned into the expression vector pcDNA3, as control for
sequencing experiments and AS-PCR (Fig 1B). Again, we did
not ®nd the Pro162 form. As both AS-PCR and direct sequencing
should detect a Pro162 allele in heterozygous individuals, 80
different alleles were found to be negative. Moreover, the
occurrence of a Pro162 variant has not been reported by other
groups who studied larger numbers of individuals with different
pigmentation phenotypes (Box et al, 1997; Smith et al, 1998). Thus
the Pro162 form is an extremely infrequent variant, or alternatively,
the original reported sequence was in error at this position, and the
Arg162 allele is referred to as wild-type in the following discussion.
We next analyzed the functional properties of the Pro162
variant. Two clones of CHO cells stably expressing either the
Pro162 or the wild-type allele were selected, based on their high
levels of MC1R mRNA, and on their expression of physiologic
levels of receptor (between 500 and 7000 molecules per cell).
Pro162 clones failed to respond to the superpotent analog NDP-
MSH ([Nle4, D-Phe7]-aMSH) with increases in intracellular
cAMP. Wild-type clones exhibited normal dose±response curves
(Fig 2A). Moreover, the Pro162 variant transiently overexpressed
in 293T cells also failed to respond to NDP-MSH (Fig 2B).
Conversely, clones stably expressing the Pro162 variant bound
NDP-MSH with an even higher af®nity than the Arg162 protein
(Fig 2C). In summary, the Arg/Pro162 substitution is a loss-of-
function mutation that leads to a conformational state able to bind
hormone with unusually high af®nity, but unable to undergo the
conformational transition necessary for effective coupling to Gs.
At least four mutations in the second intracellular loop of
MC1R, Arg142His, Arg151Cys, Arg160Trp (SchioÈth et al, 1999),
and Arg162Pro, impair receptor function. Interestingly, none of
these mutations impairs hormone binding. It can be concluded that
the second intracellular loop of MC1R is a major determinant for
activation and coupling to Gs, but not for melanocortin binding.
Natural mutations in the second intracellular loop of MC1R should
be considered potentially important because they might lead to
loss-of-function and increased melanoma risk.
Supported by grant PM99-0138 from the CICYT, Spain.
Celia JimeÂnez-Cervantes, ConcepcioÂn Olivares, Petra GonzaÂlez,
Renato Morandini,* Ghanem Ghanem,*
JoseÂ Carlos GarcõÂa-BorroÂn
Department of Biochemistry and Molecular Biology, School of
Medicine, University of Murcia, Spain
*Laboratory of Oncology and Experimental Surgery (LOCE),
Free University of Brussels, Brussels, Belgium
REFERENCES
Abdel-Malek Z, Swope V, Suzuki Y, et al: Mitogenic and melanogenic stimulation of
normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA
92:1789±1793, 1995
Box N, Wyeth J, O'Gorman L, Martin N, Sturm R: Characterization of melanocyte
stimulating hormone receptor variant alleles in twins with red hair. Hum Mol
Genet 6:1891±1897, 1997
Chhajlani V, Wikberg JE: Molecular cloning and expression of the human
melanocyte stimulating hormone receptor cDNA. FEBS Lett 309:417±420,
1992
Figure 2. Functional analysis of the Pro162 MC1R variant.
Transfections were performed using the SuperFect reagent (Qiagen,
Germany). (A) Functional coupling of the Pro162 and wild-type alleles
stably expressed in CHO-K1 cells. Cells grown to semicon¯uence in
HAMS F12 containing 10% fetal calf serum, 1 mM pyruvate, 100 U
penicillin per ml, 100 mgstreptomycin sulfate per ml, 400 mg geneticin
per ml, and 2.5 mg amphotericin B per ml, were serum-deprived 24 h
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radioimmunoassay (Amersham Pharmacia Biotech, Little Chalfont,
Buckinghamshire, UK). Bars represent the mean 6 SD for triplicate
values. Similar results were obtained with two different clones,
expressing approximately 500 and 700 receptors per cell for the Pro162
variant, and 700 and 6000 receptors per cell for the Arg162 wild-type
allele. (B) Lack of functional coupling of the Pro162 variant transiently
overexpressed in 293T cells. Cells were transfected with pcDNA vector,
or with the Pro162 and Arg162 constructs. NDP-MSH-induced cAMP
accumulation was measured as above. Bars represent the mean 6 SD for
triplicate values. Similar results were obtained in three independent
experiments. (C) The Pro162 variant binds NDP-MSH with high
af®nity. Displacement curves were obtained using clones of CHO-K1
cells stably expressing the Pro162 (j) and Arg162 (.) alleles. 106 cells
were incubated at 37°C with 125I-NDP-MSH (speci®c activity 1 mCi
per mg), in 0.1 M phosphate buffer, pH 7.4, in the presence of different
concentrations of unlabeled hormone. Cells were washed twice with
phosphate buffer, and the associated radioactivity was measured. Each
data point represents the mean 6 SD of triplicate values.
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Melanosomal pH, Pink Locus Protein and their Roles in
Melanogenesis
To the editor:
We read with interest the article by Puri et al (2000) that reports
aberrant pH of melanosomes in pink-eyed dilution (p) mutant
mouse melanocytes. Although it is recognized that the product of
pink-eyed dilution locus (P protein) is important for melanogenesis
its speci®c function has not yet been identi®ed. In their paper Puri
et al propose that the P-protein is involved in acidi®cation of
melanosomal pH and that this acidic pH is essential for
melanogenesis. This proposal is based on the ®nding of a reduced
localization of the melanogenic enzyme TRP-1 in acidic
organelles. Whilst this could suggest that p-mutant mouse
melanocytes have fewer acidic melanosomes there are other
interpretations. For instance, it could be argued that in these
melanocytes there is a misrouting of TRP-1 protein.
It would indeed be a unique ®nding if, as Puri et al suggest, the
p-locus product is an ionic transporter involved in acidi®cation of
melanosomes. If this was the case then it is dif®cult to explain how
the P-protein, which does not utilize energy from ATP, could
function against a proton gradient of up to 1000-fold (pH 7.2 in
cytosol versus pH < 4 in melanosomes); however, this hypothesis
can be easily tested. If, as postulated by the authors, melanogenesis
only occurs in acidic melanosomes then it follows that neutraliz-
ation of intracellular acidic organelles should lead to a reduction of
melanogenesis in wild-type cells. The same change in p null mouse
melanocytes should result in little if any decrease in melanogenesis
as most melanosomes are already at a neutral pH. There are several
well-characterized substances available that neutralize intracellular
acidic organelles that could be used to test this hypothesis. These
include the selective vacuolar type proton pump inhibitors,
ba®lomycinA1 (BafA1) and concanomycinA (ConA), the H+/
Na + exchanger monensin, and ammonium chloride (NH4Cl).
Although Puri et al used monensin in their experiments to
demonstrate the speci®city of their method to visualize acidic
organelles, they made no mention of its effects on melanogenesis.
This was surprising since there are reports that treatment of mouse
melanoma cells with monensin or NH4Cl will cause immediate and
large increases in melanogenesis (Saeki and Oikawa, 1985; Fuller
et al, 1993). These ®ndings are consistent with the view that
mammalian tyrosinase has optimal conditions at neutral pH
(Hearing and Ekel, 1976; Townsend et al, 1984) but contrasts
with the hypothesis that acidic conditions favor melanogenesis
(Devi et al, 1987). In fact we also have observations that support the
view that melanin production is optimal at near neutral pH. We
have reported that the proton pump inhibitors, BafA1 and ConA,
induced melanogenesis in tyrosinase positive but amelanotic human
and mouse melanoma cells (Ancans and Thody, 2000) and our
observations have recently been con®rmed (Fuller et al, 2001).
Interestingly, one of the melanoma cell lines (FM3) used in our
study failed to express mRNA for the P-protein. Melanogenesis
was also restored in response to monensin and NH4Cl and in all
cultures this correlated with neutralization of acidic organelle pH.
We carried out similar experiments using the mouse melanocyte
line Melan-p1 (pcp/p25H) as well as wild-type P locus cell lines
Melan-a and Melan-b (kindly provided by Dr. D. Bennett).
Neutralization of acidic organelles resulted in a 4±5-fold increase in
the melanin content of Melan-p1 cells while there was no
signi®cant change with the Melan-a cells (wild type). Melan-b
cells that have wild-type P locus but reduced melanogenesis, as a
result of mutated b locus, responded with a slight increase in
melanin content (Fig 1). These results were not affected by the
protein synthesis inhibitor cycloheximide suggesting an activation
of pre-existing tyrosinase.
Our ®ndings are consistent with the idea that P protein has a role
in regulation of melanosomal pH but argue against the hypothesis
of acidi®cation. We would suggest the alternative hypothesis that
the P-locus protein has a role in the neutralization of melanosomal
pH and that this change facilitates tyrosinase activity. P-locus
protein is homologous to the E. coli Na+/H + antiporter and in
the light of our ®ndings it is reasonable to propose that the
P-protein functions as a channel that acts to reduce the proton
concentration inside the melanosome (as these organelles are related
to lysosomes). The observation made by Puri et al that both p null
melanocyte lines had a 25% increase in the total number of acidic
vesicles would be in keeping with this. Finally, our hypothesis does
not contradict the fact that melanosomes can be acidic; however,
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Figure 1. Effect of acidic intracellular organelle neutralization on
melanogenesis in mouse melanocytes with wild type p-locus
(Melan-a and b) and the pcp/p25H line Melan-p1. The cells were
treated with BafA1 (20 nM), monensin (10 mM), or NH4Cl (10 mM)
for 24 h and mean values of three experiments 6 SD are represented. *p
< 0.05; **p < 0.001.
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